LOS ANGELES -- The StatLock Foley catheter securement device reduced catheter-associated urinary tract infections (CAUTIs) by 45 percent in a prospective, randomized, multicenter study, according to an abstract presented at the annual meeting of the Society for Healthcare Epidemiology of America (SHEA).
The presentation was made by the study's principal investigator, Rabih Darouiche, MD, professor and director of the Center for Prostheses Infection at Baylor College of Medicine (Houston, Texas). The conference was held April 9-12 in Los Angeles.
The study compared StatLock securement of indwelling urinary catheters to traditional methods for securing such catheters. The traditional methods included tape, a Velcro strap, the Cath-Secure device, and no securement. The study involved 118 patients with spinal cord injury and four medical facilities over a more than two-year period.
"These results are clinically very relevant," Darouiche said. "Most of the approaches to preventing CAUTIs that have been tried previously have employed an antimicrobial strategy. Because those methods have yielded conflicting results or proven to be ineffectual, it made sense to look elsewhere for effective prevention. The StatLock device, by possibly reducing both tissue damage and shear-forces on bacterial biofilm, has now been demonstrated to have a substantial clinical impact on the most prevalent of all device-related nosocomial infections, CAUTIs."
"The results of this study are consistent with two previous pilot studies, both of which suggested that proper securement of Foley catheters could reduce CAUTIs," said Steve Bierman, MD, the company's founder and inventor of StatLock. "With this study, StatLock Foley has proven to be the most clinically effective and cost-effective method of preventing CAUTIs yet discovered."
Nosocomial infections, or infections that originate in hospitals, affect about 2 million patients in the U.S. per year, and result in an estimated 90,000 deaths. CAUTIs are the leading nosocomial infection, accounting for about 35 percent of all cases. The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has made reduction of nosocomial infections one of its key National Patient Safety Goals for 2005. JCAHO's infection control standards specifically require organizations to address CAUTIs.
Traditionally, methods such as systemic antibiotics and introduction of antimicrobial agents into the bladder have been used to prevent CAUTIs. These measures have produced little or no reduction in the overall rate of infection, however, and have also been associated with adverse events and possible antibiotic resistance.
In the study presented at the SHEA meeting, adult patients with spinal cord injuries were randomly selected to have their indwelling urinary catheters secured either with the StatLock Foley device or a traditional method. CAUTIs were diagnosed in only 13.3 percent of the experimental group (StatLock), compared to 24.1 percent of the control group patients. This constitutes a 45 percent reduction of CAUTIs in patients whose catheters were secured with StatLock.
Researchers concluded that the "anti-infective property of the StatLock securing device could be due to less mucosal irritation and perhaps reduced disruption of the biofilm surrounding the catheter."
StatLock is used in more than 2,000 healthcare facilities worldwide, including Memorial Sloan-Kettering Cancer Center, Beth Israel Deaconess Medical Center, and the Cleveland Clinic. Custom StatLock designs are available for peripheral IVs, central venous, PICC, Foley and arterial catheters, as well as virtually all other medical catheters and tubes.
Venetec International is the acknowledged leader in the $2 billion catheter securement market. The company has agreements for StatLock usage with many healthcare organizations, including Novation, Premier, Inc., and the Veterans Health Administration. StatLock devices are included in safety infusion systems made by Baxter Healthcare, B. Braun, Arrow International, BD (Becton Dickinson), C.R. Bard, Cook, Inc., Kendall/Tyco, and others.
Source: Venetec International
Herpes and Dentistry: A Silent But Serious Concern
February 21st 2025Herpes infections pose significant risks in dentistry. JoAnn Gurenlian, RDH, PhD, presented prevention, treatment, occupational hazards, and a potential breakthrough in gene therapy that could revolutionize herpes management at the Midwinter Meeting.
Chicago Dental Society Honors Drs Joseph Hagenbruch and Mark Lingen for Excellence in Dentistry
February 21st 2025The Chicago Dental Society honored Dr. Joseph Hagenbruch and Dr. Mark Lingen for their leadership, research, and dedication to advancing dentistry and improving oral health care access.
From Sterilization Tech to Infection Control Advocate: Sherrie Busby’s Inspiring Dental Journey
February 20th 2025Sherrie Busby, EDDA, CDSO, CDIPC, shares her journey from dental assisting to infection control advocacy, highlighting her passion for education, her role at Heartland Dental, and her exciting transition to a new chapter.
Innovation and Infection Control: Highlights From W&H at Chicago Dental Midwinter Society Meeting
February 19th 2025Doris Schneider, senior marketing manager for North America for W&H North America, shares insights into the 160th Chicago Dental Society Midwinter Meeting, showcasing the Lexa Mini rapid sterilizer and Sanaa Power handpiece, designed for efficient sterilization and effortless dental procedures.